MDUFMA Addresses In Vitro Diagnostics, Combination Product Regulation
This article was originally published in The Gray Sheet
Executive Summary
FDA will be required to report to Congress on Center for Biologics Evaluation & Research review times for in vitro diagnostics under the "Medical Device User Fee and Modernization Act" of 2002 (MDUFMA), which cleared the House Energy & Commerce Committee Oct. 2